CONCLUSIONS: Substantial evidence implicates serotonin in the neurobiology of ADHD and in the regulation of the catecholaminergic systems believed to be dysregulated by the disorder. Yet this evidence is incomplete and, at times, conflicting. It does suggest, however, that medications that engage the serotonin system should be tested for their efficacy in the treatment of ADHD.
